The aim of this study was to assess the efficacy of PCR methodology in establishing the diagnosis of cutaneous leishmaniasis in patients from areas of endemicity in Venezuela. Biopsies from 233 patients with cutaneous ulcers suggestive of leishmaniasis were analyzed by PCR, employing oligonucleotides directed against conserved regions of kinetoplast DNA (kDNA), and the PCR products were then hybridized to nonradioactively labeled, species-specific, cloned kDNA fragments. The ability of PCR to detect Leishmania cells was compared with those of the conventional methodologies: skin testing with killed promastigotes (Montenegro test), examination of Giemsa-stained biopsy smears, and in vitro culture of biopsy tissue. The PCR-hybridization technique detected the presence of Leishmania cells in 98% of patients clinically diagnosed as having leishmaniasis and also positive by the Montenegro skin test. In comparison, leishmania positivity was found in only 42% of cultures and 64% of biopsy smears. By hybridizing the PCR product to new kDNA probes specific for either Leishmania mexicana or Leishmania braziliensis, we found that both species are major causes of cutaneous leishmaniasis in Venezuela, and the species identification was confirmed by restriction enzyme analysis of kDNA from biopsy cultures. This work demonstrates that PCR coupled with hybridization is useful not only for the diagnosis of cutaneous leishmaniasis but also for the taxonomic discrimination essential for both epidemiology and therapy. This technique can be used to diagnose leishmaniasis in a country in which the disease is endemic and can perhaps be adapted for use in a rural clinic.
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Leishmaniasis represents a major public health problem. It is estimated that there are 12 million cases worldwide, and approximately 350 million people are thought to be at risk (10) . In Venezuela alone, a mean of 2,000 cases per year was reported during the period 1988 to 1990 (files, Epidemiology Section, Instituto de Biomedicina, Caracas, Venezuela). The etiologic agents, protozoal parasites of the genus Leishmania, are transmitted by infected sand flies. About 20 species of Leishmania are known to infect humans, causing a spectrum of symptoms ranging from simple self-healing skin ulcers to disseminated cutaneous lesions and life-threatening visceral disease.
We have previously shown (9) that different clinical forms of leishmaniasis can be produced by morphologically similar parasites, and a major problem over the past decade has been to develop the means to identify and differentiate the species of parasites responsible for the various clinical forms of the disease. Because mixed infections, containing other members of the order Kinetoplastida (19, 32) or more than one leishmanial species, also occur, precise taxonomic identification of parasites is essential for epidemiologic studies (1, 2, 5, 20) .
The diagnosis of leishmaniasis (13) has traditionally been made by direct identification of leishmania amastigotes in tissue samples or smears, coupled with delayed-type hypersensitivity skin testing (25) amastigotes is rapid and easy to perform but does not distinguish between species, and the sensitivities of direct staining and smears are only 60 to 65% (12) .
In Latin America, Leishmania braziliensis and Leishmania mexicana are the two species complexes that cause cutaneous and mucosal disease. The importance of discriminating between these two complexes for therapeutic decisions was confirmed in a recent report from Guatemala, which showed that the natural history and response to chemotherapy appear to be related to the species of organism found in an ulcer, L. mexicana or L. braziliensis (16, 28) . Each of these species complexes comprises several subspecies (19) , whose identification is critical for epidemiology of vectors and reservoirs but probably is not essential in choosing appropriate therapy.
It is clear that better methods are needed that will allow accurate identification of Leishmania spp. and also satisfy the following criteria: (i) direct and rapid identification of parasites in vectors, reservoirs, and tissue biopsies, especially biopsies of early or self-healing lesions; (ii) the ability to distinguish different pathogenic species; and (iii) ease of application to countries where the disease is endemic.
Over the past several years, significant progress in developing techniques for epidemiology and diagnosis has been made. One approach has been the development of monoclonal antibodies for the identification of Leishmania species and subspecies (24) . Another technique has been the use of total mitochondrial DNA (kinetoplast DNA) (kDNA) or cloned fragments of this DNA as molecular hybridization probes that can discriminate among species and subspecies (3, 4, 6, 7, 18, 21, 22, 31, 38 (25) .
Skin biopsies of 5 to 10 mm in diameter were taken under sterile conditions from the border of the ulcer and divided into several segments, one each for PCR, smear, histopathology, and culture. The smear was performed by touching the biopsy to a glass microscope slide and then staining it with Giemsa. Subsequently, 50 high-power fields (magnification, 10OX) were searched for Leishmania organisms with a light microscope. The biopsy segment for PCR was placed directly in lysis buffer (10 mM Tris-HCI, 10 mM EDTA). Biopsies can be taken in the field and kept in lysis buffer at ambient temperature for up to 1 week and still yield results by microscopy and PCR equivalent to those obtained when the sample is processed immediately. Cultures of biopsies were performed as described elsewhere (36) .
PCR. In the laboratory, proteinase K was added to the samples in lysis buffer to a final concentration of 200 ,ug/ml. The samples were then heated to 56°C for 30 min, after which the temperature was increased to 94°C for 30 min to inactivate the enzyme. After centrifugation at 800 x g for 1 min, the supernatant was transferred to a clean tube and the tissue pellet was discarded. The PCR mixture (25 Isolation of kDNA species-specific probes. kDNA was isolated from reference strains of L. mexicana (PH8) and L. braziliensis (M2903), digested to completion with EcoRI, and ligated to pBR322 cut with EcoRI and treated with calf intestine alkaline phosphatase (Boehringer Mannheim). The ligation mixture was transformed into Eschenichia coli JM105 and plated on Luria broth (LB)-ampicillin plates. The colonies were transferred to nitrocellulose discs, denatured, and renatured as described elsewhere (33) biopsy from a leprosy patient; 6 through 13, products of PCRs using samples from processed patient ulcer biopsies.
measuring optical density at 260 nm (OD260) (1 0D260 unit = 50 ,ug of double-stranded DNA).
Restriction enzyme analysis of kDNA. Approximately 1 ,ug of kDNA was digested with 2 U of MspI (Bethesda Research Laboratories) at 37°C overnight. After the addition of a 1/10 volume of sample buffer (0.05% xylene cyanol, 0.05% bromophenol blue, 50% glycerol), the digested kDNA samples were electrophoresed on a gradient polyacrylamide gel (4.5 to 10% polyacrylamide) in TAE buffer at 8 mA overnight. The gels were then stained with 10% silver nitrate (AgNo3) by the method described by Beidler et al. (8) . kDNA isolated from positive biopsy cultures was cut with restriction enzyme MspI, and the resulting digest patterns were compared with patterns obtained with MspI digests of kDNA from international reference strains PH8 and M2903.
RESULTS
Detection of leishmania parasites. The first objective of this study was to assess the ability of PCR to detect leishmanial parasites in clinical biopsies and to compare PCR with other commonly used detection methods. Biopsies were taken from 233 patients presenting with ulcers consistent with leishmaniasis and also reacting positively to a Montenegro skin test. For the PCR amplification, we used primers 13A and 13B (30) (see Materials and Methods), which are targeted to a region of minicircle kDNA that is broadly conserved in leishmanial species and yield a PCR product 120 bp in length (Fig. 1) . In the PCR, leishmanial parasites were detected in biopsies from 97% (226 of 233) of patients, yielding a PCR product 120 bp in length (Fig. 1) . Control PCRs using 20 biopsies of healthy skin and five biopsies of lepromatous skin, as well as human lymphocytes and cultures of Trypanosoma cruzi, were all negative.
In comparison (Fig. 2) , leishmanial organisms were seen in touch preparation smears from only 63% of these biopsies. Fragments of the biopsy tissue were also placed onto media: 43% grew leishmania colonies, 27% were negative, and 30% of the cultures were contaminated and discarded. Of the seven patients whose biopsies were negative by PCR, none was positive by smear or culture; two were diagnosed as having mycotic infections, and five were lost to follow-up, left untreated.
Taxonomy. The PCR primers used detected the presence of all Leishmania species and do not distinguish among them. However, we sought to clone fragments of kDNA that are species specific and could be hybridized to the PCR product to identify the species in the biopsy (30) . Therefore, total kDNA from reference strains PH8 and M2903 was digested with restriction enzyme EcoRI, and the fragments were ligated into plasmid pBR322. Recombinant plasmids were then hybridized to total kDNA of both species in order to In preliminary studies, it was found that the PCR products amplified with primers 13A and 13B hybridized strongly to one or the other of the two clones, but not to both. The PCR products amplified from patient biopsies were then spotted on duplicate nitrocellulose filters and hybridized to both clones. Biopsies were classified as containing L. mexicana or L. braziliensis according to the clone to which their PCR product hybridized (Fig. 3 and 4) . Of the 226 total positive biopsies, 117 hybridized to the L. mexicana-specific clone pALM3 and 109 hybridized to L. braziliensis-specific clone pALB5. As (Fig. 5A ), but Hinfl, HaeIII, EcoRI, and HindIl did not (17) .
kDNA was then isolated from over 60 positive biopsy cultures and digested with restriction enzyme MspI, and the resulting patterns were compared with MspI digests of kDNA from the reference strains. In all cases, the species designation the identification obtained by hybridization of the PCR product with the species-specific clones (Fig. SB) . In addition, when kDNA from the positive cultures was hybridized by dot blot to total kDNA of both L. mexicana and L. braziliensis (38) , the hybridization to the species found to be present by both kDNA restriction enzyme digest and the PCR-hybridization technique was invariably much stronger (data not shown).
DISCUSSION
New World cutaneous leishmaniasis predominantly afflicts rural populations in developing countries, and new diagnostic techniques must be proven applicable in this setting. The traditional diagnostic methods are easily employed-direct microscopy can be performed at any clinic with a reasonable microscope, and cultures can be set up in a central laboratory-but their sensitivities are unacceptably low. When we attempted to detect parasites by these methods, we obtained results comparable to those described in other reports (11, 23, 27, 37) : 64% of our biopsy smears were positive by direct microscopy, and Leishmania parasites were grown from only 42% of biopsy cultures. The low percentage of positives by both techniques is probably due to the paucity of parasites present in the lesions and the low sensitivity level of the tests. Culture, which might be expected to be more sensitive, actually gave fewer positive results, perhaps because the ulcers are often secondarily infected with bacteria or fungus, and many cultures are contaminated and discarded.
In contrast, the PCR-hybridization technique detected the presence of leishmania parasites in 97% of our ulcer biopsies. PCR is especially suited to situations where few organisms are found, and it has been shown (30) that the primers we used can detect the presence of as few as 10 leishmanial parasites. Another advantage of the PCR-hybridization technique is that it does not require rigorous sterility; in our study, the same biopsy fragment was routinely touched to a microscope slide for smears and then placed in buffer and kept for up to 10 days before being processed for PCR. Because the probes are specific for leishmanial targets, moderate contamination of the biopsies with other organisms should not affect PCR results.
Of the seven patients whose biopsies were negative, two VOL. 32, 1994 ,,,j . 4 _ * 4 6 , , . B t , X . , . _ t | _ -. , ' ' ' : ' s . . : : : . ' . . , t S ' b ' ' S ' t . The different species and subspecies of Leishmania can be distinguished by monoclonal antibodies (24) , isoenzyme analysis, or restriction digests of kDNA (26, 29, 34, 35) , but these techniques require a quantity of parasites obtainable only by in vitro culture.
In our study, we identified the species of the parasites by hybridizing the PCR product to species-specific clones of kDNA, thus eliminating the need for biopsy cultures. These probes were selected empirically as kDNA fragments of L. mexicana and L. braziliensis that will hybridize much more strongly to their own species. The accuracy of species identification by using these probes was confirmed by restriction enzyme digestion of total kDNA isolated from over 60 positive cultures. The minor differences in the restriction patterns of the Venezuelan isolates from those of the reference strains, or from each other (for example, in Fig. 5A compare lanes 3 through 8 with each other and with lane 2), likely reflect differences at the subspecies or strain level. Lane 2 in Fig. 5A contains L. mexicana subsp. amazonensis, but the clinical isolates in lanes 3 through 8 have not been characterized at the subspecies level and may belong to a different subspecies. Nevertheless, all have patterns clearly distinguishable from the pattern of L. braziliensis in Fig. 5A , lane 1. In addition, species assignment by this analysis was invariably in agreement with the species assignment by PCR-hybridization. In future work, we hope to isolate kDNA fragments that are specific for subspecies and can be hybridized to the PCR product to allow subspecies identification. It may also be possible to develop new PCR primers that will amplify only one subspecies.
While leishmania epidemiology and control are aided by subspecies discrimination, therapeutic decisions currently require only distinction of L. braziliensis from L. mexicana. The ulcers caused by L. braziliensis are generally more virulent and respond only to pentavalent antimonial drugs, while L. mexicana ulcers tend to be less severe, are more likely to heal spontaneously, and appear to respond to ketoconazole (16, 28) . The pentavalent antimonial drugs have potential toxicities, so if the parasites in an ulcer can be identified as L. mexicana, it might be better to observe the ulcer for a few weeks to see if it will heal spontaneously or treat it with ketoconazole. Ulcers infected with L. braziliensis are unlikely to heal spontaneously and will probably require treatment with a pentavalent antimonial drug. A new therapeutic approach with promising results is immunotherapy (10) with BCG and killed promastigotes. Although all of the patients in our study were initially treated with immunotherapy, the PCR methodology will be essential for determining whether there are equal levels of efficacy and protection against infections caused by both species.
L. braziliensis infection can also recur as a destructive mucocutaneous lesion that appears months to years after the original skin ulcer has healed. The greatest value of the PCR-hybridization technique may be in rapidly identifying those patients whose ulcers contain this species and who should therefore receive a full course of a pentavalent antimonial drug in order to prevent a later recurrence of the infection as mucocutaneous disease.
When We believe that this work demonstrates not only that the PCR-hybridization technique can accurately and reliably detect Leishmania parasites and identify their species, but also that it can readily be employed in a country where the disease is endemic. The digoxigenin-labelled probes, which can be made in advance and reused, allow a high degree of sensitivity without the use of radioactivity. It is even possible that the entire protocol could be adapted for use in a rural clinic with three water baths replacing the thermocycler and the gel electrophoresis omitted. This technique, or modifications of it, should rapidly alter the epidemiology, identification of vectors and reservoirs, diagnosis, and treatment of leishmaniasis in Latin America.
